ZHEJIANG-DAHUA-TECH
10.5.2021 15:47:05 CEST | Business Wire | Press release
Dahua Technology, a world-leading video-centric smart IoT solution and service provider, has recently released its upgraded WizMind series, offering a comprehensive project-oriented product portfolio and flexible AI solutions that focus on human, vehicle, object and thermal technology to empower vertical markets with enhanced AI experience.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210510005414/en/
Human-based Applications
Adopting topnotch AI chip and algorithms, the upgraded human-based WizMind solution includes privacy protection 2.0, face recognition 2.0, human video metadata 2.0 and other advanced AI performance to enable timely responses to incidents while providing accurate customer flow, crowd density, target direction, etc. to assist in further business analysis. Privacy Protection 2.0 offers additional occlusion options (irregular polygons, mosaics, and colored blocks) and supports code exporting based on specified targets, ensuring privacy safety of people and places.
Vehicle-based Applications
The upgraded vehicle-based WizMind solution integrates ANPR, parking space management, vehicle metadata 2.0 and other technologies to serve multiple vehicle-based scenes. It can accurately detect and display parking status and number of available parking spaces, and supports overlaying a variety of information on the vehicle’s snapshot. Moreover, a dual-PTZ system can even capture detailed images of vehicles under occlusion.
Object-based Applications
As a brand new feature of the upgraded WizMind, the Dahua object monitoring technology utilizes deep-learning algorithms to detect up to six kinds of objects. It can effectively filter out false alarms caused by interference and provide customers with accurate alarm information. Through the linkage alarm connected to the administrator, it can help passenger find missing items, or detect a blockage at the fire exit, thus reducing property loss and increasing safety level.
Thermal Imaging Applications
Dahua thermal imaging technology adopts the industry-leading thermal imaging sensor and excellent image processing algorithm to deliver 24/7 long-range surveillance performance. Its abnormal behavior detection, high-accurate alarms and other AI-enabled intelligent analysis functions make it ideal for airports, border security, infrastructures, fire prevention, etc.
WizMind Ecosystem
Dahua WizMind is compatible with a variety of third-party platforms. It provides sufficient API to allow integration with Dahua partners’ systems. Dahua DHOP supports third-party access to WizMind IPC and thermal cameras, enabling customization of flexible camera functions.
Boasting accurate, reliable and comprehensive AI-powered technical highlights, the upgraded WizMind series brings high-end customized solutions and convenience to users with project needs in traffic management, building, retail, energy and many other industries.
*Product launch date might vary depending on countries.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210510005414/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release
In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release
IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom